Contract W81XWH04P0530
Research And Diagnostic Systems, Inc · Department Of Defense · April 19, 2004
Research And Diagnostic Systems, Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on April 19, 2004 for $10,000 of work in biological product (except diagnostic) manufacturing. Performance is in MD. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- W81XWH04P0530
- Award type
- Purchase Order
- Pricing
- Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- In Vitro Diagno Substances,Reagents
- Place of performance
- MD
- First action
- April 19, 2004
Description
200408!000699!2100!W81XWH!US ARMY MEDICAL RESEARCH ACQ ACT!W81XWH04P0530 !A!N! !N! ! !20040419!20040503!087248183!087248183!196687362!N!R & D SYSTEMS, INC !614 MCKINLEY PL
Modification timeline
-
April 19, 2004Base award200408!000699!2100!W81XWH!US ARMY MEDICAL RESEARCH ACQ ACT!W81XWH04P0530 !A!N! !N! ! !20040419!20040503!087248183!087248183!196687362!N!R & D$9.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Greer Laboratories, Inc. | Department Of Defense | December 19, 2025 | $470.4K |
| Greer Laboratories, Inc. | Department Of Defense | December 18, 2025 | $0 |
| Lifestream Blood Bank | Department Of Defense | December 18, 2025 | $29.7K |
| Kemp Proteins, Llc | Department Of Defense | December 18, 2025 | $40.0K |
| Applied Dna Sciences, Inc. | Department Of Defense | December 15, 2025 | $1 |
| Sanofi Vaccines Us Inc. | Department Of Defense | December 12, 2025 | $486.7K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W81XWH04P0530?
Contract W81XWH04P0530 is a federal contract awarded to Research And Diagnostic Systems, Inc by Department Of Defense on April 19, 2004 for $10,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract W81XWH04P0530?
Research And Diagnostic Systems, Inc won contract W81XWH04P0530 from Department Of Defense.
How much is contract W81XWH04P0530 worth?
Contract W81XWH04P0530 has obligated $10,000 to date.